Methotrexate–Etoposide–Ifosfamide Compared with Doxorubicin–Cisplatin–Ifosfamide Chemotherapy in Osteosarcoma Treatment, Patients Aged 18

Methotrexate–Etoposide–Ifosfamide Compared with Doxorubicin–Cisplatin–Ifosfamide Chemotherapy in Osteosarcoma Treatment, Patients Aged 18–25 Years

Published:2020-04-01 Issue:2 Volume:9 Page:172-182
ISSN:2156-5333
Container-title:Journal of Adolescent and Young Adult Oncology
language:en
Short-container-title:Journal of Adolescent and Young Adult Oncology

Author:

Marec-Berard Perrine¹,Laurence Valérie²,Occean Bob-Valéry³,Ray-Coquard Isabelle⁴,Linassier Claude⁵,Corradini Nadège⁶,Collard Olivier⁷,Chaigneau Loïc⁸,Cupissol Didier⁹,Kerbrat Pierre¹⁰,Saada-Bouzid Esma¹¹,Delcambre Corinne¹²,Gouin François¹³,Guillemet Cécile¹⁴,Jimenez Marta¹⁵,Lervat Cyril¹⁶,Gaspar Nathalie¹⁷,Le Deley Marie-Cécile¹⁸,Brugieres Laurence¹⁷,Piperno-Neumann Sophie²

Affiliation:

1. Unité de Traitement de la Douleur de l'Enfant, Centre Léon Bérard, Institut d'Hématologie et d'Oncologie Pédiatrie, Lyon, France.

2. Department of Medical Oncology, Institut Curie, Paris, France.

3. Biostatistics and Epidemiology Unit, Institut Gustave Roussy, Villejuif, France.

4. Centre Léon Bérard, University Claude Bernard, Lyon, France.

5. Department of Cancer Medicine, Centre Hospitalo-Universitaire, Tours, France.

6. Department of Pediatric and Adolescent Hematology-Oncology, Hôpital Mère-Enfant, Nantes, France.

7. Department of Medical Oncology, Institut de Cancérologie de la Loire, Lucien Neuwirth, St Priest en Jarez, France.

8. Department of Medical Oncology, CHRU Jean Minjoz, Besançon, France.

9. Department of Medical Oncology, Centre Val d'Aurelle, Montpellier, France.

10. Department of Medical Oncology, Centre Eugène-Marquis, Rennes, France.

11. Medical Oncology Department, Centre Antoine Lacassagne, Nice, France.

12. Medical Oncology Department, Centre Francois Baclesse, Caen, France.

13. CHU Nantes Hôtel-Dieu/Laboratoire UMR1238 Phyos, Faculté de Médecine de Nantes, Nantes, France.

14. Medical Oncology Department, Centre Henri Becquerel, Rouen, France.

15. R&D Unicancer, Paris, France.

16. Pediatric Oncology Unit–Adolescents and Young Adults, Centre Oscar Lambret, Lille, France.

17. Department of Pediatric Oncology, Institut Gustave Roussy, Villejuif, France.

18. Biostatistics and Methodology Unit, Institut Gustave Roussy, Villejuif, France.

Publisher

Mary Ann Liebert Inc

Subject

Oncology,Pediatrics, Perinatology, and Child Health

Link

https://www.liebertpub.com/doi/pdf/10.1089/jayao.2019.0085

Reference27 articles.

1. The Adolescent and Young Adult with Cancer: State of the Art - Bone Tumors

2. Chemotherapeutic adjuvant treatment for osteosarcoma: Where do we stand?

3. Osteosarcoma: Current Treatment and a Collaborative Pathway to Success

4. EURAMOS-1, an international randomised study for osteosarcoma: results from pre-randomisation treatment

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Long term survival in adult osteosarcoma patients treated with a two-drug regimen: Final results of the OSAD93 phase II study of the FSG-GETO;European Journal of Cancer;2024-09

2. Zoledronic acid enhances tumor growth and metastatic spread in a mouse model of jaw osteosarcoma;Oral Diseases;2024-02-20

3. Nano-Based Drug Delivery Systems: Potential Developments in the Therapy of Metastatic Osteosarcoma—A Narrative Review;Pharmaceutics;2023-12-01

4. Engineered biomaterial delivery strategies are used to reduce cardiotoxicity in osteosarcoma;Frontiers in Pharmacology;2023-10-03

5. Efficacy of Recombinant Human Endostatin plus Neoadjuvant Chemotherapy for Osteosarcoma and Its Influence on Serum VEGF and MMP-9 Levels;Journal of Oncology;2023-02-25